CPT code 15273 captures the application of a skin substitute (such as an allograft or xenograft) to cover wounds on the trunk, arms, or legs measuring at least 100 cm2. This code is clinically important because skin substitutes are a growing component of complex wound management and reconstructive care, with implications for clinical outcomes, utilization patterns, and payer coverage policies across the country. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical scope of the code, typical sites of service, and the patient populations to which it applies (adults and children under defined area-based rules). The publication provides benchmarks and policy context relevant to national coverage and billing practice, clarifies reporting conventions for the initial covered area (first 100 cm2 for patients aged 10 and older; first 1 percent of body area for children under 10), and outlines common modifiers used with this service. Data not available in the input are identified where applicable. This summary equips billing managers, clinicians, and policy analysts with a concise reference to the clinical use and billing context of CPT code 15273.